{"id":2515,"date":"2026-01-12T08:22:44","date_gmt":"2026-01-12T08:22:44","guid":{"rendered":"https:\/\/minervainstitute.fi\/?p=2515"},"modified":"2026-01-12T08:26:25","modified_gmt":"2026-01-12T08:26:25","slug":"minervastiftelsens-symposium-2025-2","status":"publish","type":"post","link":"https:\/\/minervainstitute.fi\/sv\/minervastiftelsens-symposium-2025-2\/","title":{"rendered":"Minervastiftelsens symposium 2025"},"content":{"rendered":"<p><strong>Minervastiftelsens symposium 2025 samlade ledande experter inom medicinsk forskning f\u00f6r att diskutera de senaste framstegen n\u00e4r det g\u00e4ller att f\u00f6rst\u00e5 och behandla olika sjukdomar. Evenemanget \u00e4gde rum p\u00e5 Hanaholmen i Esbo den 23\u201324 oktober 2025.<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Under tv\u00e5 dagar delade forskare fr\u00e5n hela v\u00e4rlden med sig av sina insikter om hur genetiska uppt\u00e4ckter kan omvandlas till nya behandlingsmetoder och praktisk anv\u00e4ndning inom sjukv\u00e5rden. Evenemanget v\u00e4lkomnade forskare, akademiker, l\u00e4kare och andra yrkesverksamma inom medicinsk forskning, men \u00e4ven studenter och allm\u00e4nheten.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Professor Vesa Olkkonen, f\u00f6rest\u00e5ndare f\u00f6r Minervainstitutet, beskrev evenemanget som framg\u00e5ngsrikt.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u2013 Vi hade en stor publiktillstr\u00f6mning, och de f\u00f6rstklassiga f\u00f6rel\u00e4sningarna av v\u00e4rldsledande experter v\u00e4ckte livliga diskussioner, s\u00e4ger Olkkonen.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Det tv\u00e5 dagar l\u00e5nga evenemanget bestod av fyra sessioner samt en avslutande paneldiskussion. \u00c4mnena och talarna f\u00f6r \u00e5rets symposium var:<\/span><\/p>\n<p><b>Steatotisk leversjukdom (fettlever) \u2013 Att anv\u00e4nda genetik f\u00f6r att hitta nya behandlingar<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Panu Luukkonen, Minervastiftelsens institut f\u00f6r medicinsk forskning<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Russell Goodman, Harvard\/Massachusetts General Hospital, Boston, USA<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Shawn Burgess, UT Southwestern, USA<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Sami Qadri, Minervastiftelsens institut f\u00f6r medicinsk forskning<\/span><\/li>\n<\/ul>\n<p><b>Inkretiner \u2013 Fr\u00e5n laboratorium till patient<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Petter Bjornstad, University of Washington, Seattle, USA<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">David Cherney, University of Toronto, Kanada<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Ian de Boer, University of Washington, Seattle, USA<\/span><\/li>\n<\/ul>\n<p><b>Ben- och mineralmetabolism: Genetiska komponenter och behandlingsmetoder<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Wim van Hul, University of Antwerp, Belgien<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Harald J\u00fcppner, Harvard\/Massachusetts General Hospital, Boston, USA<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Outi M\u00e4kitie, Folkh\u00e4lsan, Helsingfors universitet, HUS, Finland<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Heikki Koistinen, Minervastiftelsens institut f\u00f6r medicinsk forskning<\/span><\/li>\n<\/ul>\n<p><b>Genetik och farmakogenetik inom skr\u00e4ddarsydd medicin<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Vilma Lammi, FIMM, Helsingfors universitet samt Broad Institute of MIT and Harvard, Cambridge, MA, USA<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Adrian Krainer, Cold Spring Harbor Laboratory, NY, USA<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mikko Niemi, Helsingfors universitet, Finland<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Elisabeth Wid\u00e9n, FIMM, Helsingfors universitet, Finland<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Symposiet avslutades med en paneldiskussion p\u00e5 temat: <\/span><i><span style=\"font-weight: 400;\">Nya framv\u00e4xande terapier \u2013 v\u00e4gen fr\u00e5n innovation till kostnadseffektiva patientf\u00f6rdelar<\/span><\/i><span style=\"font-weight: 400;\">. I panelen deltog Ian de Boer, Petter Bjornstad, Daniel Gordin, Harald J\u00fcppner, Adrian Krainer och Wim van Hul. Sami Pakarinen agerade moderator f\u00f6r diskussionen.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Minervastiftelsen och dess forskningsinstitut f\u00f6ljer aktivt de hetaste och snabbast v\u00e4xande omr\u00e5dena inom biomedicinsk vetenskap, vilket ocks\u00e5 \u00e4r relevant f\u00f6r institutets egen forskning. N\u00e4sta symposium kommer att h\u00e5llas 2027.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Om Minervastiftelsen<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Minervastiftelsens symposium anordnas vartannat \u00e5r av Minervastiftelsen \u2013 en privat institution som verkar f\u00f6r att fr\u00e4mja medicinsk och biovetenskaplig forskning i Finland. Stiftelsen st\u00f6djer banbrytande vetenskapliga studier och fr\u00e4mjar internationellt samarbete f\u00f6r att \u00f6ka f\u00f6rst\u00e5elsen f\u00f6r, och behandlingen av, olika sjukdomar. Symposiet fungerar som en plattform f\u00f6r att dela de senaste forskningsr\u00f6nen och fr\u00e4mja dialog mellan ledande experter p\u00e5 omr\u00e5det. Symposiet \u00e4r helt oberoende och finansieras av Minervastiftelsen.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Minervastiftelsens symposium 2025 samlade ledande experter inom medicinsk forskning f\u00f6r  [&#8230;]<\/p>\n","protected":false},"author":7,"featured_media":2030,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-2515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-okategoriserad"],"_links":{"self":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/posts\/2515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/comments?post=2515"}],"version-history":[{"count":2,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/posts\/2515\/revisions"}],"predecessor-version":[{"id":2517,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/posts\/2515\/revisions\/2517"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/media\/2030"}],"wp:attachment":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/media?parent=2515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/categories?post=2515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/tags?post=2515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}